Neurodegenerative Disease clinical trials

Explore recruiting neurodegenerative disease clinical trials.

Recruiting neurodegenerative disease studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neurodegenerative Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The BioFINDER 2 study - improved diagnostics and increased understanding of the pathophysiology of cognitive disorders

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A Continuation Study of Latozinemab in Participants with Neurodegenerative Disease

Germany, Portugal, Italy, Netherlands, Belgium, France +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

BBB-PET; Evaluation of [18F]MC225 to measure P-glycoprotein function in neurodegenerative disease

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Influence of Dexmedetomidine on the Human Glymphatic Cerebrospinal Fluid Flow, Neural Activity and Cerebral Blood Flow in Functional Magnetic Resonance Imaging (GlymphDex)

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

NeuroPET GBG 001 - Mapping pathogenic processes associated with the development of neurodegenerative disorders using novel neuroimaging modalities

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

MEDICAL CANNABIS FOR NEURODEGENERATIVE DISEASES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II CLINICAL TRIAL (NEUROBIS)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Neurodegenerative Disease trials by city

Neurodegenerative Disease clinical trials

Recruiting neurodegenerative disease studies right now

Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)

Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15

A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s Disease

Clinical Outcome Assessment for AT & BCI

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Far-Infrared Therapy for the Effect of Alzheimer Disease Dementia

Psilocybin Therapy for Depression in Parkinson's Disease

A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Also recruiting in Europe

The BioFINDER 2 study - improved diagnostics and increased understanding of the pathophysiology of cognitive disorders

A Continuation Study of Latozinemab in Participants with Neurodegenerative Disease

BBB-PET; Evaluation of [18F]MC225 to measure P-glycoprotein function in neurodegenerative disease

Influence of Dexmedetomidine on the Human Glymphatic Cerebrospinal Fluid Flow, Neural Activity and Cerebral Blood Flow in Functional Magnetic Resonance Imaging (GlymphDex)

NeuroPET GBG 001 - Mapping pathogenic processes associated with the development of neurodegenerative disorders using novel neuroimaging modalities

MEDICAL CANNABIS FOR NEURODEGENERATIVE DISEASES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II CLINICAL TRIAL (NEUROBIS)

Neurodegenerative Disease trials by city

Other conditions